tiprankstipranks
Trending News
More News >
Biofil Chemicals & Pharmaceuticals Ltd. (IN:BIOFILCHEM)
:BIOFILCHEM
India Market

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) Financial Statements

Compare
0 Followers

Biofil Chemicals & Pharmaceuticals Ltd. Financial Overview

Biofil Chemicals & Pharmaceuticals Ltd.'s market cap is currently ₹756.73M. The company's EPS TTM is ₹0.12; its P/E ratio is 136.68; Biofil Chemicals & Pharmaceuticals Ltd. is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 334.02M₹ 400.35M₹ 300.35M₹ 223.82M₹ 357.50M
Gross Profit₹ 20.91M₹ 25.28M₹ 25.63M₹ 28.66M₹ 32.68M
Operating Income₹ 4.68M₹ 4.17M₹ 7.39M₹ 9.05M₹ 11.87M
EBITDA₹ 11.53M₹ 13.06M₹ 12.65M₹ 14.83M₹ 23.99M
Net Income₹ 5.58M₹ 7.09M₹ 5.60M₹ 6.98M₹ 12.41M
Balance Sheet
Cash & Short-Term Investments₹ 2.55M₹ 22.84M₹ 377.00K₹ 1.45M₹ 4.41M
Total Assets₹ 509.60M₹ 470.83M₹ 314.06M₹ 187.32M₹ 332.38M
Total Debt₹ 4.71M₹ 4.39M₹ 5.22M₹ 4.65M₹ 4.30M
Net Debt₹ 3.39M₹ -18.45M₹ 4.85M₹ 3.20M₹ -107.00K
Total Liabilities₹ 321.79M₹ 288.80M₹ 141.04M₹ 18.95M₹ 171.09M
Stockholders' Equity₹ 187.82M₹ 182.03M₹ 173.01M₹ 168.38M₹ 161.29M
Cash Flow
Free Cash Flow₹ -20.24M₹ 23.71M₹ -1.22M₹ -2.90M₹ 5.44M
Operating Cash Flow₹ -19.24M₹ 23.94M₹ -1.12M₹ -2.20M₹ 11.11M
Investing Cash Flow₹ -1.00M₹ -229.00K₹ -106.00K₹ -699.00K₹ -961.00K
Financing Cash Flow₹ -45.00K₹ -1.25M₹ 151.00K₹ -58.00K₹ -8.30M
Currency in INR

Biofil Chemicals & Pharmaceuticals Ltd. Earnings and Revenue History

Biofil Chemicals & Pharmaceuticals Ltd. Debt to Assets

Biofil Chemicals & Pharmaceuticals Ltd. Cash Flow

Biofil Chemicals & Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis